Position in GILD
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,832,037
+$309,162 QoQ
Shares Held
22,416
+23.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#730
of 2,266 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 5%
Shared 0%
None 95%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Csenge Advisory Group holds $34,699,600 across 10 Drug Manufacturers - General names. GILD ranks #6 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,327 | $6,389,364 | |
| 2 | ABBV |
AbbVie Inc.
|
25,158 | $6,330,759 | |
| 3 | JNJ |
Johnson & Johnson
|
18,196 | $4,621,238 | |
| 4 | AMGN |
Amgen Inc
|
10,362 | $3,752,287 | |
| 5 | PFE |
Pfizer Inc
|
154,984 | $3,732,014 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
22,416 | $2,832,037 | |
| 7 | NVS |
Novartis AG
|
16,110 | $2,524,759 | |
| 8 | GSK |
GSK plc
|
41,506 | $2,175,744 |
All Filings in GILD
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,832,037 | 22,416 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,522,875 | 18,102 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,714,640 | 22,117 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,374,734 | 21,394 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $566,102 | 5,106 | Shares | Sole | 2025-08-06 | |
| 2024-12-31 | $225,567 | 2,442 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $472,773 | 5,639 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $490,081 | 7,143 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $617,570 | 8,431 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,163,546 | 14,363 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,035,371 | 13,816 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $970,850 | 12,597 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $906,281 | 10,923 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $905,202 | 10,544 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $553,297 | 8,969 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $589,852 | 9,543 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $327,628 | 5,511 | Shares | Sole | 2022-05-09 | |
| No filing history on record for this holder in this stock. | ||||||